CollPlant Biotechnologies Statistics
Total Valuation
CLGN has a market cap or net worth of $6.14 million. The enterprise value is $4.53 million.
| Market Cap | 6.14M |
| Enterprise Value | 4.53M |
Important Dates
The next estimated earnings date is Wednesday, August 19, 2026, before market open.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CLGN has 18.91 million shares outstanding. The number of shares has increased by 11.54% in one year.
| Current Share Class | 18.91M |
| Shares Outstanding | 18.91M |
| Shares Change (YoY) | +11.54% |
| Shares Change (QoQ) | +7.52% |
| Owned by Insiders (%) | 51.53% |
| Owned by Institutions (%) | 9.07% |
| Float | 9.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.56 |
| Forward PS | 4.01 |
| PB Ratio | 1.00 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.41 |
| EV / EBITDA | 0.59 |
| EV / EBIT | 0.67 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.27, with a Debt / Equity ratio of 0.54.
| Current Ratio | 2.27 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | 0.35 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -151.99% and return on invested capital (ROIC) is -71.08%.
| Return on Equity (ROE) | -151.99% |
| Return on Assets (ROA) | -61.34% |
| Return on Invested Capital (ROIC) | -71.08% |
| Return on Capital Employed (ROCE) | 97.82% |
| Weighted Average Cost of Capital (WACC) | 5.57% |
| Revenue Per Employee | $9,974 |
| Profits Per Employee | -$336,769 |
| Employee Count | 39 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 1.42 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.60% in the last 52 weeks. The beta is 0.68, so CLGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | -88.60% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 0.95 |
| Relative Strength Index (RSI) | 49.15 |
| Average Volume (20 Days) | 39,150 |
Short Selling Information
The latest short interest is 16,240, so 0.11% of the outstanding shares have been sold short.
| Short Interest | 16,240 |
| Short Previous Month | 33,721 |
| Short % of Shares Out | 0.11% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.29 |
Income Statement
In the last 12 months, CLGN had revenue of $389,000 and -$13.13 million in losses. Loss per share was -$1.03.
| Revenue | 389,000 |
| Gross Profit | -574,000 |
| Operating Income | -12.95M |
| Pretax Income | -13.13M |
| Net Income | -13.13M |
| EBITDA | 7.47M |
| EBIT | 6.59M |
| Loss Per Share | -$1.03 |
Balance Sheet
The company has $4.26 million in cash and $2.65 million in debt, with a net cash position of $1.61 million or $0.09 per share.
| Cash & Cash Equivalents | 4.26M |
| Total Debt | 2.65M |
| Net Cash | 1.61M |
| Net Cash Per Share | $0.09 |
| Equity (Book Value) | 4.89M |
| Book Value Per Share | 0.34 |
| Working Capital | 3.10M |
Cash Flow
In the last 12 months, operating cash flow was -$11.30 million and capital expenditures -$25,000, giving a free cash flow of -$11.33 million.
| Operating Cash Flow | -11.30M |
| Capital Expenditures | -25,000 |
| Depreciation & Amortization | 878,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -11.33M |
| FCF Per Share | -$0.60 |
Margins
| Gross Margin | -147.56% |
| Operating Margin | -3,329.05% |
| Pretax Margin | -3,376.35% |
| Profit Margin | n/a |
| EBITDA Margin | 1,920.82% |
| EBIT Margin | 1,695.12% |
| FCF Margin | n/a |
Dividends & Yields
CLGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.54% |
| Shareholder Yield | -11.54% |
| Earnings Yield | -217.00% |
| FCF Yield | -187.13% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 7.45% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 21, 2016. It was a reverse split with a ratio of 1:1.5.
| Last Split Date | Nov 21, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:1.5 |
Scores
CLGN has an Altman Z-Score of -20.43 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -20.43 |
| Piotroski F-Score | 1 |